

NCT02406885 Raw comparison:

Summary:
CHIA has 16 criteria while your personal folder has 19 criteria
Total found criteria: 16/16
Total not Found: 0/16
Total Extra: 3
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Men or women 18 to 65 years old with a BMI of 35   │ Men or women 18 to 65 years old with a BMI of 35   │
│ kg/m2 or greater who will be undergoing bariatric  │ kg/m2 or greater who will be undergoing bariatric  │
│ surgery (VSG and RYGB)                             │ surgery (VSG and RYGB)                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Signed written informed consent                    │ Signed written informed consent                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Women of childbearing potential (WOCBP) must have  │ Women of childbearing potential (WOCBP) must have  │
│ a negative serum or urine pregnancy test (minimum  │ a negative serum or urine pregnancy test (minimum  │
│ sensitivity 25 IU/L or equivalent units of HCG)    │ sensitivity 25 IU/L or equivalent units of HCG)    │
│ within 24 hours prior to the start of study drug   │ within 24 hours prior to the start of study drug   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Women must not be breastfeeding                    │ Women must not be breastfeeding                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of documented clotting/coagulation         │ History of documented clotting/coagulation         │
│ disorder                                           │ disorder                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of cancer (within the last year)           │ History of cancer (within the last year)           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Any diagnosis requiring anti-coagulation           │ Any diagnosis requiring anti-coagulation           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of hypersensitivity reaction to apixaban   │ History of hypersensitivity reaction to apixaban   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Active clinically significant bleeding             │ Active clinically significant bleeding             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Creatinine > 1 5 mg/dL                             │ Creatinine \> 1 5 mg/dL                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Participants currently receiving any type of       │ Participants currently receiving any type of       │
│ anticoagulation or blood thinning medications      │ anticoagulation or blood thinning medications      │
│ including heparin low molecular weight heparins    │ including heparin low molecular weight heparins    │
│ Plavix aspirin NSAIDS                              │ Plavix aspirin NSAIDS                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Combined P-glycoprotein and strong cytochrome P450 │ Combined P-glycoprotein and strong cytochrome P450 │
│ (CYP) 3A4 inhibitor                                │ (CYP) 3A4 inhibitor                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Combined P-glycoprotein and moderate CYP 3A4       │ Combined P-glycoprotein and moderate CYP 3A4       │
│ inhibitor                                          │ inhibitor                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Combined P-glycoprotein inducer and strong CYP 3A4 │ Combined P-glycoprotein inducer and strong CYP 3A4 │
│ inducer                                            │ inducer                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Inducers of p-glycoprotein                         │ Inducers of p-glycoprotein                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Strong inducers of CYP 3A4                         │ Strong inducers of CYP 3A4                         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                   │
╞═══════════════════════════════════════════════════════════╡
│ Must have maximum age of 65 Years                         │
├───────────────────────────────────────────────────────────┤
│ Must have minimum age of 18 Years                         │
├───────────────────────────────────────────────────────────┤
│ Participant who is taking any of the excluded medications │
╘═══════════════════════════════════════════════════════════╛